The gynecologic oncology consult: symptom presentation and concurrent symptoms of depression and anxiety
- PMID: 15172854
- PMCID: PMC2746486
- DOI: 10.1097/01.AOG.0000127983.70739.d8
The gynecologic oncology consult: symptom presentation and concurrent symptoms of depression and anxiety
Abstract
Objective: To detail the relationship of gynecologic symptoms and sociodemographic variables to depression and anxiety reports among women who were referred to gynecologic oncologists for evaluation.
Methods: Consecutive patients (N = 151) from an National Cancer Institute-designated comprehensive cancer center were accrued and participated on the day of consultation. Patients completed measures assessing depression (Center for Epidemiological Studies Depression Scale) and anxiety (Beck Anxiety Inventory) symptoms, common gynecologic signs/symptoms, and sociodemographic characteristics. Patients were followed up and subsequent diagnoses yielded 73 (48%) cancer and 78 (52%) benign cases.
Results: Descriptive analyses revealed that the cancer group was significantly older (52 versus 45 years) than the benign group, and variables correlated with age also differed significantly, with the cancer sample more likely to be postmenopausal, unemployed, and if employed, working fewer hours per week. Importantly, the groups did not differ on reports of depressive, anxiety, or gynecologic symptoms. Hierarchical multiple regression analyses, collapsing across groups, yielded significant correlates of emotional distress. Women who were older, without a spouse/partner, and who had more gynecologic symptoms had higher levels of both depressive and anxiety symptoms. Among the women who did have a partner, those with relationships of longer duration reported lower levels of depression/anxiety
Conclusion: Reports of clinically significant depressive (42%) and anxiety symptoms (30%) were high. The number of gynecologic symptoms was reliably correlated with emotional distress. Age and absence of partner may have conferred added vulnerability. For those women with partners, lengthier relationships appeared to offer protection from both depressive and anxiety symptoms.
Level of evidence: III
Similar articles
-
Predictors of depression and anxiety symptom trajectories in the 24 months following diagnosis of breast or gynaecologic cancer.Breast. 2016 Apr;26:100-5. doi: 10.1016/j.breast.2016.01.008. Epub 2016 Feb 17. Breast. 2016. PMID: 27017248
-
Comparison of the hospital anxiety and depression scale and the center for epidemiological studies depression scale for detecting depression in women with breast or gynecologic cancer.Gen Hosp Psychiatry. 2014 Jan-Feb;36(1):74-80. doi: 10.1016/j.genhosppsych.2013.08.010. Epub 2013 Nov 5. Gen Hosp Psychiatry. 2014. PMID: 24200105
-
Proof-of-Concept of an Integrated Yoga and Psychological Intervention in Mitigating Distress Among Diverse Women With Gynecologic, Gastrointestinal, and Thoracic Cancers.Integr Cancer Ther. 2024 Jan-Dec;23:15347354241283113. doi: 10.1177/15347354241283113. Integr Cancer Ther. 2024. PMID: 39423043 Free PMC article.
-
Telephone interventions for symptom management in adults with cancer.Cochrane Database Syst Rev. 2020 Jun 2;6(6):CD007568. doi: 10.1002/14651858.CD007568.pub2. Cochrane Database Syst Rev. 2020. PMID: 32483832 Free PMC article.
-
Antidepressant treatment with sertraline for adults with depressive symptoms in primary care: the PANDA research programme including RCT.Southampton (UK): NIHR Journals Library; 2019 Dec. Southampton (UK): NIHR Journals Library; 2019 Dec. PMID: 31869013 Free Books & Documents. Review.
Cited by
-
Quality of life among women after surgery for ovarian cancer.Palliat Support Care. 2008 Sep;6(3):239-47. doi: 10.1017/S1478951508000497. Palliat Support Care. 2008. PMID: 18662417 Free PMC article. Clinical Trial.
-
Developing and assessing a vomiting-free ward workflow for gynecological patients receiving chemotherapy.Support Care Cancer. 2025 Apr 5;33(4):358. doi: 10.1007/s00520-025-09422-9. Support Care Cancer. 2025. PMID: 40188225
-
Effects of a nursing intervention on quality of life outcomes in post-surgical women with gynecological cancers.Psychooncology. 2009 Jan;18(1):62-70. doi: 10.1002/pon.1365. Psychooncology. 2009. PMID: 18570223 Free PMC article. Clinical Trial.
-
Anxiety and depression symptoms in the 2 years following diagnosis of breast or gynaecologic cancer: prevalence, course and determinants of outcome.Support Care Cancer. 2015 Aug;23(8):2215-24. doi: 10.1007/s00520-014-2571-y. Epub 2015 Jan 6. Support Care Cancer. 2015. PMID: 25559036
-
Frequency and duration of suffering of cervical cancer patients and caregivers: Results from an international Delphi study.PLOS Glob Public Health. 2023 Mar 9;3(3):e0001642. doi: 10.1371/journal.pgph.0001642. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 36963037 Free PMC article.
References
-
- Bodurka-Bevers D, Basen-Engquist K, Carmack CL, Fitzgerald MA, Wolf JK, de Moor C, et al. Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecol Oncol. 2000;78:302–8. - PubMed
-
- Kornblith AB, Thaler HT, Wong G, Vlamis V, Lepore JM, Loseth DB, et al. Quality of life in women with ovarian cancer. Gynecol Oncol. 1995;59:231–42. - PubMed
-
- Thompson DS, Shear MK. Psychiatric disorders and gynecological oncology: a review of the literature [review] Gen Hosp Psychiatry. 1998;20:241–7. - PubMed
-
- Locke BZ, Regier DA. Prevalence of selected mental disorders. In: Taube CA, Barrett SA, editors. Mental Health United States. Rockville (MD): National Institute of Mental Health; 1985. pp. 1–6.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials